Physician profile
Stuart Green
NPI 1881702504
$1,325,112.28
in general payments reported to CMS, 2019-2025
8 companies · $51K in 2025
The $51K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220K · 2020: $47K · 2021: $224K · 2022: $315K · 2023: $324K · 2024: $144K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $465K · Consulting Fee: $49K · Food and Beverage: $4,828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $465,254.12 |
| Consulting Fee | $49,300.00 |
| Food and Beverage | $4,827.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive Specialized Orthopedics, INC. | $869,679.35 | 2019-2023 | Precice Intramedullary Limb Lengthening System |
| Smith+Nephew, INC. | $362,476.83 | 2019-2025 | Na, Ilizarov, Q-Fix |
| Globus Medical, INC. | $92,447.04 | 2024-2025 | Precice Intramedullary Limb Lengthening System, Precice® Intramedullary Limb Lengthening System |
| Nuvasive, INC. | $196.08 | 2019-2023 | Precice Intramedullary Limb Lengthening System |
| Medical Device Business Services, INC. | $135.65 | 2019 | |
| Bioventus LLC | $98.82 | 2025 | Exogen Ultrasound Bone Healing System |
| Radius Health, INC. | $62.16 | 2019 | |
| Pacira Therapeutics, INC. | $16.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.